Author: lappaadm

February 8, 2022 | Controlled Substances, Criminal Justice, Harm Reduction, Medication Assisted Treatment (MAT), Naloxone, Opioids, Prescription Drugs, Public Health, Recovery, Substance Misuse, Toolkits, Treatments

The 2022 AMA-Manatt Toolkit builds on a previously published roadmap by providing actionable resources that states can use to take specific actions in six policy areas: (1) Increase access to evidence-based treatments to help patients with a substance use disorder (SUD); (2) Ensure access to addiction medicine, psychiatry, and other trained physicians; (3) Enforce mental health and substance use disorder (SUD) parity laws; (4) Improve access to multidisciplinary, multimodal care for patients with pain; (5) Expand harm reduction efforts to reduce death and disease; and (6) Improve monitoring and evaluation....

February 7, 2022 | Case Law Monitor

Each issue of Case Law Monitor highlights unique cases from around the United States in the areas of public health and safety, substance use disorder, and the criminal justice system. Every other month, LAPPA updates readers on cases that are important to the field....

January 6, 2022 | News Bites

Each issue of News Bites highlights unique news articles from around the United States in the areas of public health and safety, substance use disorder, and the criminal justice system. Every other month, LAPPA updates readers on news they may have missed....

January 5, 2022 | Fact Sheets, Harm Reduction, Opioids, Public Health, Public Safety, Sharps/Syringes

Syringe Services Programs (SSPs) are harm reduction programs that provide a wide range of services including, but not typically limited to, the provision of new, unused hypodermic needles and syringes and other injection drug use supplies, such as cookers, tourniquets, alcohol wipes, and sharps waste disposal containers, to people who inject drugs. SSPs, initially limited to the exchange of hypodermic needles and syringes and often still called needle or syringe exchange programs, have been present in the United States in some form since the early 1980s. Often illegal due to drug paraphernalia laws – an issue that still exists today – only seven U.S. cities had programs by the end of 1991.  According to the Centers for Disease Control and Prevention (CDC), in November 2007, there were 185 SSPs in 36 states, the District of Columbia, and Puerto Rico. As of February 2022, that number has increased to 414 operational SSPs in all 50 states, the District of Columbia, and Puerto Rico, although only 38 states, the District of Columbia, and Puerto Rico either explicitly or implicitly authorize SSPs through statute or regulation. This fact sheet provides readers with an overview of SSPs, including the components that make up a...

December 10, 2021 | Controlled Substances, Criminal Justice, Harm Reduction, Opioids, Prescription Drugs, Public Health, Recovery, Reports & Studies, Substance Misuse, Treatments

The Bloomberg School of Public Health at Johns Hopkins University recently released a three-part report about the multi-district opioid litigation that has been making its way through the court system for many years. Part 1 of the trilogy, focuses on a series of principles governing the use of the settlement funds: (1) spending money to save lives; (2) using evidence to guide spending; (3) investing in youth prevention; (4) focusing on racial equity; and (5) developing a fair and transparent process for deciding where to spend the funding....

December 7, 2021 | Controlled Substances, Harm Reduction, Model Laws, Opioids, Public Health, Public Safety, Sharps/Syringes, Substance Misuse

The Model Syringe Services Program Act authorizes the establishment of comprehensive syringe services programs, which are associated with a decrease in bloodborne infectious disease diagnoses as well as the number of needlestick injuries to first responders and others. This Act delineates the required components for syringe services programs operating within a state, including that such programs: (1) directly provide, or offer referrals to, expanded services, such as substance use disorder treatment, including medications for addiction treatment, HIV and viral hepatitis testing and treatment services, access to opioid antagonist kits, health care services, and mental health services; (2) reduce needlestick injuries to law enforcement, emergency services personnel, sanitation workers, and members of the community; (3) provide data collection and reporting requirements for syringe services programs; (4) provide immunity from criminal arrest, charge, and prosecution for the possession, distribution, or furnishing of hypodermic needles and syringes and other supplies; (5) provide educational and training materials for members of the community, including law enforcement and other first responders, such as emergency medical services; and (6) provide for funding of syringe services programs....

December 7, 2021 | Case Law Monitor

Each issue of Case Law Monitor highlights unique cases from around the United States in the areas of public health and safety, substance use disorder, and the criminal justice system. Every other month, LAPPA updates readers on cases that are important to the field....

November 2, 2021 | News Bites

Each issue of News Bites highlights unique news articles from around the United States in the areas of public health and safety, substance use disorder, and the criminal justice system. Every other month, LAPPA updates readers on news they may have missed....